Some hospitals not prepared for potential Ebola patients

Article

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease.

As healthcare workers in West Africa battle against Ebola, some experts in the United States question whether American hospitals would be able to protect their employees and the public should the disease spread. 

Report: U.S. health care costs significantly higher than other countries

Under the watchful eye of the Centers for Disease Control and Prevention (CDC), Emory University Hospital in Atlanta is treating two American missionaries who were infected with the disease while in Liberia.

According to the CDC, symptoms of the disease include fever, headache, joint and muscle aches, weakness, diarrhea, vomiting, stomach pain, lack of appetite, and abnormal bleeding. Symptoms may appear anywhere from two to 21 days after exposure to ebolavirus. Ebola can be transmitted only through direct contact with blood or bodily fluids of a symptomatic person or through exposure to objects, such as needles, that have been contaminated.

A recent Fox News opinion piece noted that the danger comes from someone who is unknowingly infected with Ebola travels to the United States and goes to an emergency room after he becomes symptomatic.

“Many hospitals are poorly prepared to contain any pathogen. That’s why at least 75,000 people a year die from hospital infections,” writes Betsy McCaughey, PhD, former Lt. Governor of New York. 

“Whether Americans die of Ebola will depend largely on what hospitals do when the first victims unknowingly carrying the virus are admitted,” says Dr. McCaughey.

The CDC recently issued a notice reminding U.S. healthcare workers of the importance of taking steps to prevent the spread of this virus, how to test and

“The CDC also needs to improve its own infection control rigor. In the last three months, three incidents of the CDC mishandling pathogens-anthrax, avian flu, and smallpox-have come to light. Why assume the agency’s ready for Ebola?” writes Dr. McCaughey.

Formulary News: WHO okays experimental drug use in Ebola outbreak

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.